ABPWW
Abpro Holdings Inc
Set alert
- YTD
- -77.39%
- 1 year
- -77.39%
- Open
- 0.0025
- Prev close
- 0.0026
- Mkt cap
- 621.77K
- Vol
- 7.89K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0025
- High
- 0.0026
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 72.00K
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 63.00K
- Total debt
- 6.28M
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
About Abpro Holdings Inc
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- abpro.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ABPWW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Saba Capital Management, L.P. | 6.65% | 997,048 | 119.64K | Sep 29, 2024 |
| JP Morgan Chase & Company | 5.88% | 882,280 | 105.87K | Sep 29, 2024 |
| MMCAP International, Inc. SPC | 4.50% | 675,000 | 81.00K | Sep 29, 2024 |
| AQR Arbitrage LLC | 4.35% | 652,964 | 78.36K | Sep 29, 2024 |
| Calamos Advisors LLC | 4.17% | 625,000 | 75.00K | Sep 29, 2024 |
| Highbridge Capital Management, LLC. | 3.90% | 584,305 | 70.12K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Saba Capital Income & Opportunities Fd | 0.54% | 80,774 | 9.69K | Jul 30, 2024 |
| First Tr Exchange Traded Fd-First Trust Alternative Opportunities Fd | 0.00% | 522 | 62 | Sep 29, 2024 |